Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulants and thrombolytics: what's the difference?

M L Workman

    AACN Clinical Issues in Critical Care Nursing
    |February 1, 1994
    PubMed
    Summary

    Anticoagulant and thrombolytic therapies are distinct treatments for blood clots. Understanding the differences between inhibiting clot formation and dissolving existing clots is crucial for effective patient care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of virtual reality on symptom distress in children receiving chemotherapy.

    Cyberpsychology & behavior : the impact of the Internet, multimedia and virtual reality on behavior and society·2009
    Same author

    Virtual reality as a distraction intervention for older children receiving chemotherapy.

    Pediatric nursing·2002
    Same author

    Genetics counseling. Good intentions do not absolve misinformation.

    Nursing leadership forum·2002
    Same author

    Immune mechanisms in rheumatic disease.

    The Nursing clinics of North America·2000
    Same author

    The lymphoid system and its role in maintaining immunocompetence.

    Seminars in oncology nursing·1998
    Same author

    Oncology nursing education.

    Annual review of nursing research·1996

    Area of Science:

    • Cardiovascular Medicine
    • Hematology
    • Pharmacology

    Background:

    • Drug therapy is essential for treating myocardial infarction and thrombotic stroke.
    • Blood clotting cascade inhibition is widely used in various healthcare settings.
    • Healthcare providers often confuse anticoagulant and thrombolytic therapies.

    Purpose of the Study:

    • To clarify the physiological differences between intrinsic and extrinsic blood clotting pathways.
    • To differentiate between anticoagulant and thrombolytic drug therapies.
    • To address the common misconception equating these two therapeutic approaches.

    Main Methods:

    • Review of the physiology of the blood clotting cascade.
    • Analysis of the mechanisms of action for anticoagulant drugs.
    • Analysis of the mechanisms of action for thrombolytic drugs.

    Main Results:

    • Detailed explanation of intrinsic and extrinsic clotting pathways.
    • Clear distinction between drugs that prevent clot formation and those that dissolve existing clots.
    • Identification of specific scenarios where each therapy is indicated.

    Conclusions:

    • Anticoagulant and thrombolytic therapies are not interchangeable.
    • Accurate understanding of these drug classes is vital for appropriate clinical application.
    • Distinguishing between these therapies improves treatment efficacy for thrombotic events.

    Related Experiment Videos